ANDA 062655

LILLY

FDA Drug Application

Application #062655

Application Sponsors

ANDA 062655

LILLY

Marketing Status

• Discontinued: 001
• Discontinued: 002

Application Products

001	INJECTABLE;INJECTION	1GM/VIAL	0	TAZIDIME	CEFTAZIDIME
002	INJECTABLE;INJECTION	2GM/VIAL	0	TAZIDIME	CEFTAZIDIME

FDA Submissions

	ORIG	1	AP	1985-11-20
LABELING; Labeling	SUPPL	4	AP	1992-02-14
LABELING; Labeling	SUPPL	5	AP	1992-02-14
LABELING; Labeling	SUPPL	6	AP	1999-02-25
MANUF (CMC); Manufacturing (CMC)	SUPPL	7	AP	1992-10-30
MANUF (CMC); Manufacturing (CMC)	SUPPL	8	AP	1993-10-18
LABELING; Labeling	SUPPL	9	AP	1996-02-26
LABELING; Labeling	SUPPL	10	AP	1996-07-15
LABELING; Labeling	SUPPL	13	AP	2007-11-20

Submissions Property Types

SUPPL	7	Null	0
SUPPL	8	Null	0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62655
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)